Marrone Bio Innovations Company Profile (NASDAQ:MBII)

About Marrone Bio Innovations (NASDAQ:MBII)

Marrone Bio Innovations logoMarrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.

Industry, Sector and Symbol: Capitalization:
  • Market Cap: $29.88 million
  • Outstanding Shares: 31,351,000
Average Prices:
  • 50 Day Moving Avg: $1.11
  • 200 Day Moving Avg: $1.26
  • 52 Week Range: $0.85 - $2.79
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.06
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $16.95 million
  • Price / Sales: 1.79
  • Book Value: ($1.14) per share
  • Price / Book: -0.85
  • EBITDA: ($21,120,000.00)
  • Net Margins: -177.10%
  • Return on Assets: -64.21%
  • Debt-to-Equity Ratio: -1.63%
  • Current Ratio: 1.37%
  • Quick Ratio: 0.98%
  • Average Volume: 102,911 shs.
  • Beta: 0.29
  • Short Ratio: 17.79

Frequently Asked Questions for Marrone Bio Innovations (NASDAQ:MBII)

What is Marrone Bio Innovations' stock symbol?

Marrone Bio Innovations trades on the NASDAQ under the ticker symbol "MBII."

How were Marrone Bio Innovations' earnings last quarter?

Marrone Bio Innovations, Inc. (NASDAQ:MBII) posted its quarterly earnings results on Monday, August, 14th. The company reported ($0.25) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.04. The company earned $6.48 million during the quarter, compared to analysts' expectations of $6.62 million. View Marrone Bio Innovations' Earnings History.

Where is Marrone Bio Innovations' stock going? Where will Marrone Bio Innovations' stock price be in 2017?

3 equities research analysts have issued 12-month target prices for Marrone Bio Innovations' stock. Their predictions range from $1.00 to $4.00. On average, they anticipate Marrone Bio Innovations' stock price to reach $2.50 in the next twelve months. View Analyst Ratings for Marrone Bio Innovations.

Who are some of Marrone Bio Innovations' key competitors?

Who are Marrone Bio Innovations' key executives?

Marrone Bio Innovations' management team includes the folowing people:

  • Timothy T. Fogarty, Independent Chairman of the Board
  • James B. Boyd, President, Chief Financial Officer
  • Pamela G. Marrone Ph.D., Chief Executive Officer, Director
  • Linda V. Moore, Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
  • Brian R. Ahrens, Vice President of Sales
  • Nancy Hood, Vice President - Marketing
  • Timothy B. Johnson Ph.D., Vice President - Field Development and Technical Services
  • Keith J. Pitts, Vice President - Regulatory and Government Affairs
  • Amit Vasavada Ph.D., Vice President - Research and Development
  • Kathleen A. Merrigan Ph.D., Director

How do I buy Marrone Bio Innovations stock?

Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Marrone Bio Innovations' stock price today?

One share of Marrone Bio Innovations stock can currently be purchased for approximately $0.97.

MarketBeat Community Rating for Marrone Bio Innovations (NASDAQ MBII)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  71 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  153
MarketBeat's community ratings are surveys of what our community members think about Marrone Bio Innovations and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Marrone Bio Innovations (NASDAQ:MBII) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $2.50 (157.73% upside)
Consensus Price Target History for Marrone Bio Innovations (NASDAQ:MBII)
Price Target History for Marrone Bio Innovations (NASDAQ:MBII)
Analysts' Ratings History for Marrone Bio Innovations (NASDAQ:MBII)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/15/2017HC WainwrightSet Price TargetBuy$4.00HighView Rating Details
7/22/2017Piper Jaffray CompaniesSet Price TargetHold$1.00HighView Rating Details
5/2/2017Jefferies Group LLCReiterated RatingHold$2.50LowView Rating Details
3/16/2016Rodman & RenshawInitiated CoverageBuy$3.50N/AView Rating Details
12/31/2015Roth CapitalReiterated RatingBuy -> Not Rated$15.00N/AView Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Marrone Bio Innovations (NASDAQ:MBII)
Earnings by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Earnings History by Quarter for Marrone Bio Innovations (NASDAQ MBII)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2017Q2 2017($0.21)($0.25)$6.62 million$6.48 millionViewN/AView Earnings Details
3/29/2017Q4 2016($0.26)($0.32)$2.69 millionViewN/AView Earnings Details
11/14/2016Q316($0.22)($0.29)$4.61 million$3.63 millionViewN/AView Earnings Details
8/9/2016Q216($0.28)($0.28)$4.61 million$5.00 millionViewN/AView Earnings Details
5/12/2016Q116($0.27)($0.38)$3.05 million$2.70 millionViewListenView Earnings Details
3/30/2016Q215($0.40)($0.45)$1.10 million$1.90 millionViewListenView Earnings Details
8/7/2014Q2 2014($0.49)($0.50)$7.59 million$3.63 millionViewN/AView Earnings Details
5/13/2014Q114($0.37)($0.52)$4.63 million$2.80 millionViewN/AView Earnings Details
3/6/2014Q4 2013($0.40)($0.52)$5.80 million$5.97 millionViewN/AView Earnings Details
9/12/2013Q2 2013($0.33)($2.36)$4.33 million$4.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Marrone Bio Innovations (NASDAQ:MBII)
Current Year EPS Consensus Estimate: $-1.05 EPS
Next Year EPS Consensus Estimate: $-0.47 EPS


Dividend History for Marrone Bio Innovations (NASDAQ:MBII)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Marrone Bio Innovations (NASDAQ:MBII)
Insider Ownership Percentage: 7.25%
Institutional Ownership Percentage: 51.06%
Insider Trades by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Institutional Ownership by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Insider Trades by Quarter for Marrone Bio Innovations (NASDAQ:MBII)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/25/2017Ardsley Advisory PartnersMajor ShareholderBuy50,000$1.72$86,000.00View SEC Filing  
6/15/2016Richard E RomingerDirectorBuy10,000$0.94$9,400.00View SEC Filing  
6/13/2016James BoydCFOBuy10,000$0.79$7,900.00View SEC Filing  
6/9/2016George H KerckhoveDirectorBuy2,500$0.72$1,800.00View SEC Filing  
6/9/2016Pamela G MarroneCEOBuy5,000$0.72$3,600.00View SEC Filing  
6/9/2016Timothy B JohnsonVPBuy10,000$0.72$7,200.00View SEC Filing  
8/14/2014George H KerckhoveDirectorBuy400$5.90$2,360.00View SEC Filing  
8/12/2014Pamela G MarroneCEOBuy1,000$5.29$5,290.00View SEC Filing  
2/12/2014Ventures Pte. Ltd. Syngentamajor shareholderSell332,027$14.72$4,887,437.44View SEC Filing  
1/29/2014Donald GlidewellCFOSell75,495$17.00$1,283,415.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Marrone Bio Innovations (NASDAQ:MBII)
Latest Headlines for Marrone Bio Innovations (NASDAQ:MBII)
DateHeadline logoBRIEF-Marrone Bio signs exclusive agreement with Kenya Biologics - October 19 at 6:09 AM logoMarrone Bio Innovations Signs Exclusive Distribution Agreement with Kenya Biologics Ltd. for Kenya and Tanzania - October 19 at 6:09 AM logoComparing Israel Chemicals Shs (ICL) and Marrone Bio Innovations (MBII) - October 15 at 6:26 AM logoMarrone Bio Innovations (MBII) & Its Peers Critical Analysis - October 11 at 4:24 PM logoMarrone Bio Innovations, Inc. Receives Positive Results From Brazil Trials - October 11 at 3:19 PM logoHead to Head Survey: Marrone Bio Innovations (MBII) and The Competition - October 11 at 2:20 PM logoAll You Need To Know About Marrone Bio Innovations Inc’s (MBII) Risks - October 6 at 10:16 AM logoMarrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th - September 29 at 6:43 PM logoMarrone Bio Innovations to Present at The MicroCap Conference in New York on October 5th - GlobeNewswire (press release) - September 29 at 1:42 PM logoMarrone Bio (MBII), Elephant Vert Ink Distribution Deal - September 25 at 7:18 PM logoMarrone Bio Innovations Announces Availability of Venerate XC Bioinsecticide Product in New York - September 25 at 8:33 AM logoMarrone Bio Innovations (MBII) vs. Israel Chemicals Shs (ICL) Head-To-Head Contrast - September 24 at 2:48 PM logoReviewing Israel Chemicals Shs (ICL) & Marrone Bio Innovations (MBII) - September 19 at 2:48 PM logoReviewing Marrone Bio Innovations (MBII) & Its Rivals - September 17 at 6:16 AM logoHead-To-Head Review: Marrone Bio Innovations (MBII) versus The Competition - September 16 at 2:30 AM logoDavis-based Marrone Bio Innovations partners with app developer for pilot program - September 15 at 6:17 AM logoMarrone Bio Innovations Debuts Highlight Video from the Great Lakes Restoration Information Fair - September 15 at 6:17 AM logoMarrone Bio Innovations (MBII) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow - September 14 at 7:29 AM logoAgShift Launches Pilot Project with Marrone Bio Innovations to More Efficiently Assess the Impact of Biological Pesticides on the Quality of Fresh Produce - September 7 at 1:02 AM logoFinancial Survey: Agrium (AGU) versus Marrone Bio Innovations (MBII) - September 4 at 10:12 PM logoMarrone Bio Innovations to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 11th - August 30 at 6:24 AM logoShort Squeeze Coming In Marrone Bio Innovations? - August 28 at 8:20 PM logoETFs with exposure to Marrone Bio Innovations, Inc. : August 25, 2017 - August 26 at 7:00 AM logoComparing American Vanguard Corporation (AVD) & Marrone Bio Innovations (MBII) - August 23 at 6:28 AM logoComparing Monsanto (MON) & Marrone Bio Innovations (MBII) - August 22 at 4:08 AM logoMarrone Bio Innovations, Inc. Helps Sponsor Educational Symposia for Growers in Honduras and Chile - August 21 at 7:49 PM logoHead-To-Head Contrast: Marrone Bio Innovations (MBII) & Ciner Resources (CINR) - August 21 at 12:22 PM logoMarrone Bio Innovations, Inc. :MBII-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 - August 17 at 1:58 AM logoEdited Transcript of MBII earnings conference call or presentation 14-Aug-17 8:30pm GMT - August 16 at 6:04 AM logoMarrone Bio Innovations, Inc. (MBII) Given a $4.00 Price Target at HC Wainwright - August 15 at 6:40 PM logoMarrone Bio Innovations, Inc. (MBII) Releases Earnings Results, Misses Expectations By $0.04 EPS - August 15 at 12:38 PM logoMarrone Bio Innovations, Inc. Reports Second Quarter 2017 Financial Results - August 15 at 1:20 AM logoContrasting Marrone Bio Innovations (NASDAQ:MBII) and American Vanguard Corporation (AVD) - August 7 at 12:10 AM logoMarrone Bio Innovations, Partner Organizations Celebrate Major Milestone in Testing Invasive Zebra and Quagga Mussel Treatment under Large-Scale Open Water Conditions - August 3 at 4:19 AM logoMarrone Bio Innovations to Report Second Quarter 2017 Financial Results and Host a Conference Call on Monday, August 14th at 1:30 p.m. Pacific time - August 2 at 3:48 AM logoMarrone Bio Innovations to Present at Investor Conferences in August - July 27 at 4:12 AM logoMarrone Bio ships first products to Africa - July 25 at 3:59 AM logoMarrone Bio Innovations Expands its Products to Africa - July 24 at 12:57 PM logoMarrone Bio Innovations Inc (NASDAQ:MBII) Given a $1.00 Price Target by Piper Jaffray Companies Analysts - July 23 at 10:02 PM logoTop Marijuana Stocks on the NASDAQ - July 20 at 6:05 AM logoMarrone Bio Innovations, Inc. Products Show Impressive Results in International Trials Against Key Pests and Diseases - July 11 at 1:12 AM logoETFs with exposure to Marrone Bio Innovations, Inc. : July 5, 2017 - July 5 at 4:17 PM logoMarrone Bio Innovations (MBII) Presents At 7th Annual LD Micro Invitational Conference - Slideshow - June 9 at 12:23 AM logoMarrone Bio's (MBII) Q1 Loss in Line, Revenues Up Y/Y - May 15 at 10:32 AM logoBRIEF-Marrone Bio Innovations inks deal with Jet Harvest Solutions - May 12 at 1:58 AM logoMarrone Bio Innovations' (MBII) CEO Pam Marrone on Q1 2017 Results - Earnings Call Transcript - May 12 at 1:58 AM logoBRIEF-Marrone Bio Innovations says offering of 5.71 mln common shares priced at $1.40/share - April 26 at 6:54 PM logoUPDATE: Marrone Bio (MBII) Prices 5.71M Common Stock Offering at $1.40/Share - April 25 at 5:48 PM logoMarrone Bio raising $8 million with stock offering - April 25 at 5:48 PM logoBRIEF-Marrone Bio Innovations reports proposed public offering of common stock - April 24 at 7:16 PM



Marrone Bio Innovations (MBII) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.